Dolby Laboratories, Inc.
DLB
$72.38
$0.931.30%
NYSE
| 06/27/2025 | 03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.94% | 4.03% | 2.71% | -2.00% | -2.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.94% | 4.03% | 2.71% | -2.00% | -2.17% |
| Cost of Revenue | 8.84% | -1.10% | -0.64% | -7.91% | -7.87% |
| Gross Profit | 6.70% | 4.71% | 3.16% | -1.22% | -1.39% |
| SG&A Expenses | 5.76% | 2.35% | 1.68% | -1.30% | 0.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.44% | 0.65% | -0.14% | -2.69% | -0.71% |
| Operating Income | 17.21% | 18.66% | 15.01% | 0.72% | -7.72% |
| Income Before Tax | 22.83% | 34.34% | 37.59% | 24.97% | -3.76% |
| Income Tax Expenses | 20.31% | 32.64% | 28.61% | -0.51% | -11.58% |
| Earnings from Continuing Operations | 23.38% | 34.72% | 39.53% | 31.08% | -1.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 50.36% | -27.80% | -41.19% | -152.13% | -984.39% |
| Net Income | 24.39% | 34.79% | 39.52% | 30.48% | -3.09% |
| EBIT | 17.21% | 18.66% | 15.01% | 0.72% | -7.72% |
| EBITDA | 16.87% | 15.80% | 10.85% | -1.48% | -7.42% |
| EPS Basic | 24.05% | 34.45% | 39.57% | 30.88% | -2.69% |
| Normalized Basic EPS | 10.24% | 14.18% | 13.37% | 6.70% | 1.27% |
| EPS Diluted | 24.15% | 34.63% | 40.34% | 31.01% | -2.74% |
| Normalized Diluted EPS | 10.58% | 14.60% | 13.95% | 6.75% | 1.12% |
| Average Basic Shares Outstanding | 0.20% | 0.15% | -0.04% | -0.24% | -0.51% |
| Average Diluted Shares Outstanding | -0.21% | -0.32% | -0.59% | -0.42% | -0.34% |
| Dividend Per Share | 10.00% | 10.26% | 10.53% | 10.81% | 11.11% |
| Payout Ratio | -0.11% | -0.18% | -0.21% | -0.15% | 0.13% |